{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-25-000121","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2025-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.727526+00:00","generated_at":"2026-05-17T06:19:36.446631+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"McKesson reorganizes into 4 segments; restates FY2025 revenue of $359B under new structure","bullets":["Starting Q2 FY2026, McKesson will report 4 segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, Medical-Surgical Solutions.","FY2025 restated revenue: North American Pharm $304.5B, Oncology & Multispecialty $36.9B, Prescription Tech $5.2B, Medical-Surgical $11.4B; total $359.1B.","FY2025 restated adjusted op. profit: N.A. Pharm $3,145M (1.03%), Oncology & Multispecialty $936M (2.54%), Prescription Tech $961M (18.42%), Med-Surg $1,022M (8.98%).","Agreement to sell Norway operations signed Aug 4, 2025 (subject to regulatory approval); also intends to separate Medical-Surgical Solutions (announced May 2025).","Segment changes did not impact previously issued consolidated financials or EPS."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-25-000121","json":"https://secwatch.observer/filing/0000927653-25-000121.json","markdown":"https://secwatch.observer/filing/0000927653-25-000121.md","text":"https://secwatch.observer/filing/0000927653-25-000121.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765325000121/0000927653-25-000121-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765325000121/mck-20250918.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:19:36.446631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}